Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
NIKKEI 225
38,385.73
+29.67
(+0.08%)
HANG SENG
19,073.71
-41.35
(-0.22%)
CRUDE OIL
78.85
+0.83
(+1.06%)
GOLD FUTURES
2,391.40
+31.50
(+1.33%)
DOW
39,884.57
+326.46
(+0.83%)
Bitcoin GBP
52,244.11
+3,663.18
(+7.54%)
Money
How to claim expenses at work without breaking the rules
Knowing more about tax rules can save you money
CRISPR Therapeutics AG (CRSP)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
56.66
+0.95
(+1.70%)
As of 03:49PM EDT. Market open.
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
270,000
370,000
436
913,081
543
Cost of revenue
135,024
130,250
110,250
101,178
-
Gross profit
134,976
239,750
-109,814
811,903
-
Operating expenses
Research development
363,569
387,332
461,645
340,567
266,946
Selling general and administrative
71,755
76,162
102,464
99,690
88,208
Total operating expenses
433,614
462,288
563,347
438,375
354,978
Operating income or loss
-298,638
-222,538
-673,161
373,528
-354,435
Total other income/expenses net
83,794
71,816
22,661
6,003
6,379
Income before tax
-214,844
-150,722
-650,500
379,531
-348,056
Income tax expense
2,292
2,888
-325
1,870
809
Income from continuing operations
-217,136
-153,610
-650,175
377,661
-348,865
Net income
-217,136
-153,610
-650,175
377,661
-348,865
Net income available to common shareholders
-217,136
-153,610
-650,175
377,661
-348,865
Basic EPS
-5.29
-1.94
-8.36
4.97
-5.29
Diluted EPS
-5.29
-1.94
-8.36
4.70
-5.29
Basic average shares
65,950
79,221
77,747
75,949
65,950
Diluted average shares
65,950
79,221
77,747
80,393
65,950
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.